# Evaluating a New Therapy for Dry Eye in Patients With Sjögren's Syndrome

> **NCT07277257** · PHASE4 · RECRUITING · sponsor: **Center For Sight** · enrollment: 35 (estimated)

## Conditions studied

- Sjogren Syndrome With Keratoconjunctivitis

## Interventions

- **DRUG:** TRYPTYR (Acoltremon ophthalmic solution 0.003%)

## Key facts

- **NCT ID:** NCT07277257
- **Lead sponsor:** Center For Sight
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-02
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2025-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07277257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07277257, "Evaluating a New Therapy for Dry Eye in Patients With Sjögren's Syndrome". Retrieved via AI Analytics 2026-08-08 from https://api.ai-analytics.org/clinical/NCT07277257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*